October 3, 2019
The Company and the Principal Investigator announce the addition of sub-investigators to the clinical trial team with extensive experience assessing and treating athletes and military personnel […]
September 18, 2019
ATCell™ Expanded Autologous, Adipose-Derived Mesenchymal Stem Cells Deployed via Intravenous Infusion for the Treatment of Post Concussion Syndrome (PCS) in Retired Military and Athletes EATONTOWN, NJ […]
September 12, 2019
EATONTOWN, NJ / ACCESSWIRE / September 11, 2019 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based cellular […]
August 22, 2019
EATONTOWN, NJ / ACCESSWIRE / August 22, 2019 / American CryoStem Corporation (OTC PINK:CRYO) a leading strategic developer, marketer and global licensor of patented adipose tissue-based […]
March 20, 2019
EATONTOWN, NJ / ACCESSWIRE / March 20, 2019 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose […]
December 13, 2018
EATONTOWN, NJ / ACCESSWIRE / December 13, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose […]
December 5, 2018
EATONTOWN, NJ / ACCESSWIRE / December 4 , 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented […]
August 21, 2018
EATONTOWN, NJ / ACCESSWIRE / August 21, 2018 / American CryoStem Corporation (OTC PINK: CRYO) a leading strategic developer, marketer and global licensor of patented adipose […]
July 12, 2018
EATONTOWN, NJ / ACCESSWIRE / July 12, 2018 / American CryoStem Corporation (OTC PINK: CRYO), a leading strategic application developer, marketer, and global licensor of patented […]